drugset / Trial / NCT05560360
A Trial of DDI Between SHR1459 and Efavirenz With Healthy Subjects
NaSingle-groupOpen-labelTreatment
Summary
This study used a single-dose, open and fixed sequence design to compare the pharmacokinetics in healthy subjects.
Timeline
- Start
- 2022-11-04
- Primary completion
- 2022-12-02
- Completion
- 2023-01-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | EDRALBRUTINIB | Small molecule | 100 mg | Oral |
| Subject | Efavirenz | Other / unclassified | 600 mg | Oral |